Skip to main content
OpenTrials

Clinical trial condition

Chronic Plaque-type Psoriasis

Explore clinical trials studying Chronic Plaque-type Psoriasis. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Chronic Plaque-type Psoriasis trial results

Completed

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

NCT04207801

Conditions
Chronic Plaque-type Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • B.J Medical College & Civil Hospital Ahmedabad, Gujarat, India
  • Kempegowda Institute of Medical Sciences Bangalore, Karnataka, India
  • Sapthagiri Hospital Bangalore, Karnataka, India
  • Triveni Polyclinic Nagpur, Maharashtra, India
View Trial Details
Completed

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

NCT03553823

Conditions
Chronic Plaque-type Psoriasis, Pathological Conditions, Signs and Symptoms, Pruritus, +6 more
Locations
  • Novartis Investigative Site New Orleans, Louisiana, United States
  • Novartis Investigative Site East Windsor, New Jersey, United States
  • Novartis Investigative Site Philadelphia, Pennsylvania, United States
  • Novartis Investigative Site Dallas, Texas, United States
View all 14 locations
View Trial Details
Completed

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

NCT01828086

Conditions
Chronic Plaque-type Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Anaheim, California, United States
  • Novartis Investigative Site Encino, California, United States
  • Novartis Investigative Site North Hollywood, California, United States
View all 18 locations
View Trial Details
Completed

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

NCT00941031

Conditions
Chronic Plaque-type Psoriasis
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Pasadena, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 62 locations
View Trial Details
Completed

A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

NCT01071252

Conditions
Chronic Plaque-type Psoriasis
Locations
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site Louisville, Kentucky, United States
  • Novartis Investigative Site Rochester, New York, United States
  • Novartis Investigative Site Lake Oswego, Oregon, United States
View all 19 locations
View Trial Details

Related conditions